# Evaluate alcohol minimum unit pricing against cancer incidence

Source: https://onco.cc/ideas/idea-nl-alcohol-minimum-pricing-cancer-endpoints/  
OnCo record `idea-nl-alcohol-minimum-pricing-cancer-endpoints` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Scotland and Wales put a floor under the price of alcohol. Deaths from liver disease have already fallen. Cancer takes longer to show, so someone has to keep measuring for a decade.

## Summary

Minimum unit pricing (Scotland 2018, Wales 2020, Ireland 2022) reduced alcohol sales by about 3% and alcohol-specific deaths by about 13% within three years. Alcohol-attributable cancers (oral, oesophageal, liver, colorectal, breast) have latencies of 10-20 years, so the cancer benefit, which is a large part of the policy's justification, will only be visible if a pre-registered evaluation with cancer registry linkage is funded for the long term. Natural-experiment designs comparing Scotland with England, and dose-response by deprivation, are feasible because registries are complete.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Within 10-15 years of introduction, minimum unit pricing reduces incidence of alcohol-attributable cancers by 3-5% relative to England, with the largest reductions in the most deprived quintile, and the effect is dose-dependent on price level.
- Rationale: Cancer is the largest alcohol-attributable cause of death in the long run, but policy evaluations stop at 3-5 years. A pre-registered, decade-long registry analysis protects against both premature declarations of success and industry claims of failure.
- Proposed test: Pre-registered interrupted time-series and synthetic-control analysis using national cancer registries for Scotland, Wales, Ireland and comparators, stratified by deprivation and sex, with annual reporting; funded by public health agencies for 15 years.
- Maturity: being-tested-at-scale
- Actor: policy

## Sources

- Bottleneck evidence (Prevention we already have is not deployed): Islami et al., Proportion of cancer attributable to modifiable risk factors (CA 2018): https://doi.org/10.3322/caac.21440

## Connected records

- ideas: [Cancer warnings on alcohol labels, evaluated as a natural experiment](https://onco.cc/ideas/idea-prev-alcohol-cancer-warning-labels/), [Smoke-free generation laws with a built-in evaluation across countries](https://onco.cc/ideas/idea-prev-smokefree-generation-evaluation/)
- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Oesophageal cancer](https://onco.cc/cancers/esophageal/)
- fronts: [Diet, Exercise & Lifestyle](https://onco.cc/fronts/nutrition-lifestyle/), [Prevention & Risk](https://onco.cc/fronts/prevention/)
- technologies: [Alcohol reduction, pricing and cancer warning labels](https://onco.cc/technologies/alcohol-reduction-labelling/)
- institutions: [Cancer Research UK](https://onco.cc/institutions/cruk/), [International Agency for Research on Cancer (IARC / WHO)](https://onco.cc/institutions/iarc/)
- terms: [Alcohol-attributable cancer](https://onco.cc/terms/alcohol-attributable-cancer/)
- bottlenecks: [Prevention we already have is not deployed](https://onco.cc/bottlenecks/b-prevention-adoption/), [Weak real-world evidence and registries](https://onco.cc/bottlenecks/b-real-world-evidence/)
- key papers: [Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States](https://onco.cc/key-papers/paper-islami-ca-cancer-j-clin/)

---
JSON: https://onco.cc/api/v1/entities/idea-nl-alcohol-minimum-pricing-cancer-endpoints.json